These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 5756652)
1. [1st clinical results obtained by new corticoid-stimulation with retard effect: Synacthen Retard]. Frouchtman R Praxis; 1968 Jun; 57(23):845-8. PubMed ID: 5756652 [No Abstract] [Full Text] [Related]
2. [Symptomatic treatment of asthma]. Press P Praxis; 1968 Jan; 57(2):44-9. PubMed ID: 5756539 [No Abstract] [Full Text] [Related]
3. [Pharmacokinetics of oral theophylline in asthmatic patients on long-term corticoid therapy]. Albin H; Vinçon G; Bézier M; Pehourcq F; Cabanieu G Therapie; 1983; 38(4):333-9. PubMed ID: 6648879 [No Abstract] [Full Text] [Related]
4. [Synacthen-depot treatment during withdrawal of long-term corticotherapy in patients with asthma]. Obtulowicz K; Glowacka A Pol Tyg Lek; 1974 Apr; 29(13):519-22. PubMed ID: 4363174 [No Abstract] [Full Text] [Related]
5. [Clinical and respiratory function technical studies of the new drug combination Asthmadyn-R in asthmatic clinical states]. Gürtler J Praxis; 1967 Oct; 56(41):1401-6. PubMed ID: 5633081 [No Abstract] [Full Text] [Related]
6. A combined drug for asthmatic symptoms. Barlow PP; Burger JH Mich Med; 1967 Oct; 66(19):1259-62. PubMed ID: 6065550 [No Abstract] [Full Text] [Related]
7. New thoughts about the mechanisms of action of corticosteroids and theophylline in asthma. Svedmyr N Eur J Respir Dis Suppl; 1984; 136():115-20. PubMed ID: 6329812 [No Abstract] [Full Text] [Related]
12. [The influence of a new combination preparation on distribution disorders as well as on the alveolar oxygen and carbonic acid partial pressure]. Siehoff F; Muysers K; Worth G Arzneimittelforschung; 1966 Aug; 16(8):1115-7. PubMed ID: 6014903 [No Abstract] [Full Text] [Related]
13. [On the effect of a broncholytic-bronchosecretolytic combination preparation (N67c-AST) on the mechanics of resporation, respiration volumens and symptomatology in bronchitic syndrome]. Breuer H; Kösters W; Kluthe R Med Welt; 1967 Sep; 38():2244-9. PubMed ID: 5614954 [No Abstract] [Full Text] [Related]
14. [Drugs for the treatment of asthma. Part II: Theophylline, disodium cromoglycate and steroids (author's transl)]. Gonzalez P Rev Med Chil; 1980 Jun; 108(6):570-6. PubMed ID: 6781023 [No Abstract] [Full Text] [Related]
15. Ephedrine and theophylline in asthmatic children: quantitive observations on the combination and ephedrine tachyphylaxis. Taylor WF; Heimlich EM; Strick L; Busser R Ann Allergy; 1965 Sep; 23(9):437-40. PubMed ID: 5318774 [No Abstract] [Full Text] [Related]
16. [Clinical experiences with a new bronchodilator agent (Marax)]. Paul K Wien Med Wochenschr; 1969 Mar; 119(13):252-3. PubMed ID: 5767543 [No Abstract] [Full Text] [Related]
17. [Treatment of corticoid dependents in asthmatic persons (author's transl)]. Levendel L Prax Klin Pneumol; 1977 Jun; 31(6):592-9. PubMed ID: 406606 [No Abstract] [Full Text] [Related]
18. [Therapy and mortality in status asthmaticus]. Schindl R Munch Med Wochenschr; 1972 Aug; 114(34):1445-8. PubMed ID: 4677736 [No Abstract] [Full Text] [Related]
19. [Factors responsible for the course and long-term outcomes of bronchial asthma: chemotherapy]. Makolkin VI; Ovcharenko SI; Sheianov MV Klin Med (Mosk); 1997; 75(7):59-65. PubMed ID: 9411060 [TBL] [Abstract][Full Text] [Related]
20. Reassessing the therapeutic range for theophylline: another perspective. Weinberger MM; Hendeles L Pharmacotherapy; 1993; 13(6):598-601. PubMed ID: 8302684 [No Abstract] [Full Text] [Related] [Next] [New Search]